Drug Trial Radar · NCT04530565
Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
348
Planned (sponsor's estimate)
Start
Jan 25, 2021
Primary completion
Jul 1, 2028
Study completion Jul 1, 2028
Sponsor
- Lead sponsor
- National Cancer Institute (NCI)NIH
- Sponsor type
- NIH
- First posted
- Aug 28, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus blinatumomab. Blinatumomab is a Bi-specific T-Cell Engager ('BiTE') that may interfere with the ability of cancer cells to grow and spread. The information gained from this study may help researchers determine if combination therapy with steroids, TKIs, and blinatumomab work better than the standard of care.
Conditions
- B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
Interventions
Biospecimen CollectionProcedure
Correlative studies
BlinatumomabBiological
Given IV
Bone Marrow Aspiration and BiopsyProcedure
Undergo bone marrow aspiration and biopsy
CyclophosphamideDrug
Given IV
CytarabineDrug
Given IV or IT
DasatinibDrug
Given PO
DexamethasoneDrug
Given PO or IV
Doxorubicin HydrochlorideDrug
Given IV
Echocardiography TestProcedure
Undergo ECHO
ElectrocardiographyProcedure
Undergo ECG
Lumbar PunctureProcedure
Undergo lumbar puncture
MesnaDrug
Given IV
MethotrexateDrug
Given IV or IT
Multigated Acquisition ScanProcedure
Undergo MUGA
Ponatinib HydrochlorideDrug
Given PO
PrednisoneDrug
Given PO
Vincristine SulfateDrug
Given IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall survival (OS)Time frame: Time between randomization and death from any cause, assessed up to 10 years from the date of registration
Locations
211 sites in 3 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama
Anchorage Associates in Radiation Medicine
Anchorage, Alaska
Anchorage Radiation Therapy Center
Anchorage, Alaska
Alaska Breast Care and Surgery LLC
Anchorage, Alaska
Alaska Oncology and Hematology LLC
Anchorage, Alaska
Alaska Women's Cancer Care
Anchorage, Alaska
Anchorage Oncology Centre
Anchorage, Alaska
Katmai Oncology Group
Anchorage, Alaska
Providence Alaska Medical Center
Anchorage, Alaska
Mercy Hospital Fort Smith
Fort Smith, Arkansas
Providence Saint Joseph Medical Center/Disney Family Cancer Center
Burbank, California
Community Cancer Institute
Clovis, California
University Oncology Associates
Clovis, California
City of Hope Comprehensive Cancer Center
Duarte, California
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Irvine, California
UC San Diego Moores Cancer Center
La Jolla, California
UC Irvine Health/Chao Family Comprehensive Cancer Center
Orange, California
Yale University
New Haven, Connecticut
Augusta University Medical Center
Augusta, Georgia
Hawaii Cancer Care - Westridge
‘Aiea, Hawaii
Pali Momi Medical Center
‘Aiea, Hawaii
Queen's Cancer Center - Pearlridge
‘Aiea, Hawaii
The Cancer Center of Hawaii-Pali Momi
‘Aiea, Hawaii
Hawaii Cancer Care Inc - Waterfront Plaza
Honolulu, Hawaii
Queen's Cancer Cenrer - POB I
Honolulu, Hawaii
Queen's Medical Center
Honolulu, Hawaii
Straub Clinic and Hospital
Honolulu, Hawaii
University of Hawaii Cancer Center
Honolulu, Hawaii
Hawaii Cancer Care Inc-Liliha
Honolulu, Hawaii
Kuakini Medical Center
Honolulu, Hawaii
Queen's Cancer Center - Kuakini
Honolulu, Hawaii
The Cancer Center of Hawaii-Liliha
Honolulu, Hawaii
Kapiolani Medical Center for Women and Children
Honolulu, Hawaii
Wilcox Memorial Hospital and Kauai Medical Clinic
Lihue, Hawaii
Saint Luke's Cancer Institute - Boise
Boise, Idaho
Saint Luke's Cancer Institute - Fruitland
Fruitland, Idaho
Saint Luke's Cancer Institute - Meridian
Meridian, Idaho
Saint Alphonsus Cancer Care Center-Nampa
Nampa, Idaho
Saint Luke's Cancer Institute - Nampa
Nampa, Idaho
Saint Luke's Cancer Institute - Twin Falls
Twin Falls, Idaho
Showing 40 of 211 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.